ATE457733T1 - Lipid-a- und andere kohlenhydrat-liganden-analoga - Google Patents

Lipid-a- und andere kohlenhydrat-liganden-analoga

Info

Publication number
ATE457733T1
ATE457733T1 AT03726743T AT03726743T ATE457733T1 AT E457733 T1 ATE457733 T1 AT E457733T1 AT 03726743 T AT03726743 T AT 03726743T AT 03726743 T AT03726743 T AT 03726743T AT E457733 T1 ATE457733 T1 AT E457733T1
Authority
AT
Austria
Prior art keywords
lipid
analogs
useful
replacement
nature
Prior art date
Application number
AT03726743T
Other languages
English (en)
Inventor
Zi-Hua Jiang
R Koganty
Wladyslaw Budzynski
Original Assignee
Oncothyreon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncothyreon Inc filed Critical Oncothyreon Inc
Application granted granted Critical
Publication of ATE457733T1 publication Critical patent/ATE457733T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03726743T 2002-05-09 2003-05-09 Lipid-a- und andere kohlenhydrat-liganden-analoga ATE457733T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37864502P 2002-05-09 2002-05-09
PCT/US2003/014633 WO2003094850A2 (en) 2002-05-09 2003-05-09 Lipid a and other carbohydrate ligand analogs

Publications (1)

Publication Number Publication Date
ATE457733T1 true ATE457733T1 (de) 2010-03-15

Family

ID=29420423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726743T ATE457733T1 (de) 2002-05-09 2003-05-09 Lipid-a- und andere kohlenhydrat-liganden-analoga

Country Status (9)

Country Link
US (2) US7820627B2 (de)
EP (1) EP1549322B1 (de)
JP (1) JP5014573B2 (de)
AT (1) ATE457733T1 (de)
AU (1) AU2003228966C1 (de)
CA (1) CA2485253C (de)
DE (1) DE60331330D1 (de)
ES (1) ES2343788T3 (de)
WO (1) WO2003094850A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198400B2 (en) 2001-03-27 2012-06-12 Oncothyreon, Inc. Vaccine for modulating between T1 and T2 immune responses
EP1549322B1 (de) 2002-05-09 2010-02-17 Oncothyreon Inc. Lipid-a- und andere kohlenhydrat-liganden-analoga
TW201204410A (en) 2004-04-01 2012-02-01 Oncothyreon Inc Mucinous glycoprotein (MUC-1) vaccine
EP1896051B1 (de) 2005-06-28 2014-10-15 Oncothyreon Inc. Verfahren zur behandlung von patienten mit einem muzin-(muc-1)-impfstoff
ATE524509T1 (de) 2005-07-18 2011-09-15 Nektar Therapeutics Verzweigte funktionalisierte polymere unter verwendung von verzweigten polyolen als kernen
ITMI20060530A1 (it) * 2006-03-22 2007-09-23 Univ Milano Bicocca Antinfiammatori a struttura monosaccaridica
WO2008021367A2 (en) 2006-08-11 2008-02-21 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
ES2657392T3 (es) 2006-09-26 2018-03-05 Infectious Disease Research Institute Composición de vacuna que contiene un adyuvante sintético
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
KR101012587B1 (ko) * 2007-06-04 2011-02-01 엘지전자 주식회사 디스플레이 장치
US8604004B2 (en) * 2007-10-04 2013-12-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
EP3936122A1 (de) 2008-11-24 2022-01-12 Massachusetts Institute Of Technology Verfahren und zusammensetzung zur lokalen wirkstoffabgabe
PT2437753T (pt) 2009-06-05 2016-11-23 Infectious Disease Res Inst Adjuvantes lipídicos de glucopiranosilo sintéticos e composições de vacina contendo os mesmos
CN102329335B (zh) * 2010-07-13 2014-01-22 哈尔滨工业大学 基于季戊四醇的复合脂质,制备方法及用途
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
WO2011115684A2 (en) 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
AU2012222188A1 (en) * 2011-02-24 2013-08-15 Oncothyreon Inc. MUC1 based glycolipopeptide vaccine with adjuvant
EP3632463A1 (de) 2011-04-08 2020-04-08 Immune Design Corp. Immunogene zusammensetzungen und verfahren zur verwendung der zusammensetzungen zur induzierung humoraler und zellulärer immunreaktionen
US9273084B2 (en) 2012-04-06 2016-03-01 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
WO2013152279A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
WO2013151697A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
SMT201800368T1 (it) 2012-05-16 2018-09-13 Immune Design Corp Vaccini per l'infezione da virus-2 herpes simplex
EP3711768A1 (de) 2013-04-18 2020-09-23 Immune Design Corp. Gla-monotherapie zur verwendung in der krebsbehandlung
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
JP7097667B2 (ja) 2013-09-27 2022-07-08 マサチューセッツ インスティテュート オブ テクノロジー 無担体生物活性タンパク質ナノ構造体
CA2972635A1 (en) 2015-01-06 2016-07-14 Immunovaccine Technologies Inc. Lipid a mimics, methods of preparation, and uses thereof
WO2017027843A1 (en) 2015-08-12 2017-02-16 Massachusetts Institute Of Technology Cell surface coupling of nanoparticles
US11472856B2 (en) 2016-06-13 2022-10-18 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
JP7285828B2 (ja) 2017-09-05 2023-06-02 トルク セラピューティクス, インコーポレイテッド 治療用タンパク質組成物ならびにその作製および使用方法
EP3752182B1 (de) 2018-02-12 2024-05-15 Inimmune Corporation Toll-like-rezeptorliganden
KR20240001118A (ko) * 2021-05-31 2024-01-03 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 신규 아미노 화합물 및 그의 제조방법, 그리고, 이것을 이용한 에폭시 수지용 경화제, 에폭시 수지 조성물 및 에폭시 수지 경화물
CN114399151A (zh) * 2021-11-29 2022-04-26 阿里巴巴新加坡控股有限公司 运力订单分配方法、装置、可读程序产品及导航方法
CN116162115B (zh) * 2022-12-27 2025-09-26 华中师范大学 Toll样受体4免疫激动剂及其应用、抗病毒疫苗分子及其制备方法和应用
KR102827958B1 (ko) 2025-04-09 2025-07-03 주식회사 로우맵 피부흡수 촉진용 히알루론산 나노캡슐, 이의 제조방법 및 이를 포함한 화장료 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB614215A (en) * 1946-07-09 1948-12-10 Leslie Bradford Manufacture of polyureas
GB699080A (en) 1950-05-31 1953-10-28 Ici Ltd Production of new esters of ortho-phosphoric acid and salts thereof
US3930024A (en) * 1969-09-02 1975-12-30 Parke Davis & Co Pharmaceutical compositions and methods
DE3127503A1 (de) * 1981-07-11 1983-02-17 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4464383A (en) * 1981-11-24 1984-08-07 Itaru Yamamoto Immunomodulator containing trithiazole pentamethine cyanine derivative
US4783402A (en) * 1983-04-11 1988-11-08 Meito Sangyo Kabushiki Kaisha Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
EP0219514A4 (de) 1985-04-03 1988-04-26 Wisconsin Alumni Res Found Verfahren zum vorbeugen von krankheiten, verursacht durch gram-negatives endotoxin bei säugetieren.
JPS63139186A (ja) * 1986-11-29 1988-06-10 Hidetoshi Tsuchida 三本鎖型リン脂質化合物およびその製造方法
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5041427A (en) * 1989-07-21 1991-08-20 Wisconsin Alumni Research Foundation Lipid A derivatives
JPH0655749B2 (ja) * 1989-09-20 1994-07-27 日本たばこ産業株式会社 リピッドa単糖類縁体
FR2702306B1 (fr) 1993-03-05 1995-04-14 Alcatel Nv Procédé d'auto-alignement d'un contact métallique sur un substrat de matériau semi-conducteur.
IT1264690B1 (it) 1993-07-08 1996-10-04 Bracco Spa Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi
DE4408248A1 (de) 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
WO1995027505A1 (en) 1994-04-12 1995-10-19 Biomira, Inc. Cellular immune response-specific antigens and uses therefor
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6764840B2 (en) 1997-05-08 2004-07-20 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
IT1295460B1 (it) 1997-10-02 1999-05-12 Borgotec Tecnologie Autom Spa Metodo per impilare pacchi di piastre di circuiti stampati e relativo dispositivo di carico e scarico di pacchi per una macchina utensile.
US6043390A (en) 1998-04-03 2000-03-28 The Regents Of The University Of California Pentaerythritol lipid derivatives and nucleic-acid complexes
JP5062647B2 (ja) * 1998-07-21 2012-10-31 ロンザ アーゲー アミン類の製造方法
EP1232168B1 (de) 1999-11-15 2011-08-03 Oncothyreon Inc. Synthetische lipid-a analogen und verwendungen davon
US6699846B2 (en) 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
ES2164013B1 (es) * 2000-04-14 2003-06-16 Consejo Superior Investigacion Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales.
EP1474432A1 (de) 2002-02-04 2004-11-10 Biomira Inc. Immunstimulierende, kovalent lipid-modifizierte oligonukleotide
WO2003089574A2 (en) 2002-04-15 2003-10-30 Biomira, Inc. Synthetic glyco-lipo-peptides as vaccines
EP1549322B1 (de) 2002-05-09 2010-02-17 Oncothyreon Inc. Lipid-a- und andere kohlenhydrat-liganden-analoga

Also Published As

Publication number Publication date
EP1549322B1 (de) 2010-02-17
CA2485253C (en) 2012-07-10
CA2485253A1 (en) 2003-11-20
US7820627B2 (en) 2010-10-26
ES2343788T3 (es) 2010-08-10
DE60331330D1 (de) 2010-04-01
EP1549322A2 (de) 2005-07-06
AU2003228966A1 (en) 2003-11-11
WO2003094850A3 (en) 2004-07-29
WO2003094850A2 (en) 2003-11-20
AU2003228966B2 (en) 2009-10-01
US20120003295A1 (en) 2012-01-05
EP1549322A4 (de) 2006-07-26
JP2005538050A (ja) 2005-12-15
US8097593B1 (en) 2012-01-17
JP5014573B2 (ja) 2012-08-29
AU2003228966C1 (en) 2010-05-13
US20060040891A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
ATE457733T1 (de) Lipid-a- und andere kohlenhydrat-liganden-analoga
PT665886E (pt) Rearranjo de complexos de ciclina e suas utilizacoes
IL169896A0 (en) Methods and compositions for administering therapeutic and diagnostic agents
DE60332764D1 (de) Leitungsverbindungsmodul für eine modulare implantierbare medizinische vorrichtung
BRPI9912227B8 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
GB2458430A (en) Method for generating a reference signal sequence using grouping
MX2010004863A (es) Materiales y metodos para usarse en el procesamiento de biomasa.
MX2007007723A (es) Un biomaterial implantable y un metodo para producirlo.
WO2003029418A3 (en) Proliferation and differentiation of stem cells using extracellular matrix and other molecules
MX339068B (es) Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias.
BR9712731A (pt) Fitase a partir de feijões de soja germinados
IL152111A0 (en) Tamandarin and didemnin analogs and methods of making and using them
GT200300046A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
GB2388190B (en) Methods for measuring enzyme activity
BRPI0417943A (pt) antagonistas de receptor de crf e métodos relacionados para essa finalidade
ATE461780T1 (de) Werkzeugmaschinenkartusche
ATE497976T1 (de) Spezifisch an vygfvracl-hla-a24 bindende t-zellen-rezeptoren
EA200500005A1 (ru) Способ лечения повреждения, вызванного реперфузией после ишемии, с использованием антагонистов рецептора аденозина
AU2003288621A8 (en) Rna bioassay
NO20025738D0 (no) Metode
AR057247A1 (es) Composiciones que comprenden por lo menos una enzima para reducir el estres inmunologico
WO2004016743A3 (en) Culturing anaplasma
MXPA06009711A (es) Uso de carboxipeptidasa g para combatir la toxicidad de antifolato.
EA200500012A1 (ru) Ингибиторы активности генов воспаления и биосинтеза холестерина
DE502004009150D1 (de) Neuer endospermspezifischer pflanzenpromotor für kulturpflanzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1549322

Country of ref document: EP